Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs 6,500 people in more than 10 countries and generated revenue of €616 million in 2023. Cegedim SA is listed in Paris (EURONEXT: CGM). To learn more, please visit: www.cegedim.com And follow Cegedim on X: https://bit.ly/3HCgucL & Facebook: https://bit.ly/42i5fji & Instagram: https://bit.ly/3vWKBt7 Solutions and Services for Healthcare Companies, Solutions and Services for Healthcare Professionals, and Solutions and Services for Corporate Businesses

Sectors: IT services

[Automatic translation follows] French data protection authority Created in 1978, the CNIL is an independent administrative authority that exercises its functions in accordance with the Data Protection Act of 6 January 1978, amended on 6 August 2004. legal, right of access, regulation, files, Data Protection Act, NTIC, privacy, data, and dpo

EY exists to build a better working world, helping create long-term value for clients, people and society and build trust in the capital markets. Enabled by data and technology, diverse EY teams in over 150 countries provide trust through assurance and help clients grow, transform and operate. Working across assurance, consulting, law, strategy, tax and transactions, EY teams ask better questions to find new answers for the complex issues facing our world today. Find out more about the EY global network http://ey.com/en_gl/legal-statement Advisory, Assurance, Tax, Transactions, Audit, Mergers, M&A, Financial Services, Accounting, Professional Services, Law, Technology, Consulting, Data, Transformation, Strategy, …

Sectors: Consulting, audit

KPMG is a global network of professional firms providing Audit, Tax and Advisory services. We have 273,000 outstanding professionals working together to deliver value in 143 countries and territories. With a worldwide presence, KPMG continues to build on our successes thanks to clear vision, defined values and, above all, our people. Our industry focus helps KPMG firms’ professionals develop a rich understanding of clients'​ businesses and the insight, skills and resources required to address industry-specific issues and opportunities. The independent member firms of the KPMG network are affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. Each KPMG firm …

Sectors: Consulting, audit

Astellas Pharma is a pharmaceutical company conducting business in approximately 70 countries around the world. At Astellas, we strive to be a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into the best outcomes for patients. Operating in approximately 70 countries with more than 14,000 employees, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines Pharmaceuticals and 医薬品

Sectors: Pharmaceutical

The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients.

Sectors: Biotechnology French Cluster Public business cluster

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy

Sectors: Pharmaceutical